Skip to Content

DocMorris AG ZRSEF

Morningstar Rating
$90.00 −5.77 (6.02%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

ZRSEF is trading at a 39% discount.
Price
$90.25
Fair Value
$637.46
Uncertainty
Extreme
1-Star Price
$797.36
5-Star Price
$66.16
Economic Moat
Hkjxbq
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ZRSEF is a good fit for your portfolio.

Trading Information

Previous Close Price
$95.77
Day Range
$90.0090.00
52-Week Range
$33.00108.05
Bid/Ask
$0.01 / $572,885.25
Market Cap
$1.06 Bil
Volume/Avg
10 / 76

Key Statistics

Price/Earnings (Normalized)
Price/Sales
0.97
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

DocMorris AG is an online pharmacy company and wholesale supplier to medical practitioners in Switzerland. The Group's reportable segments are Germany, and Europe. The Germany segment comprises the mail-order business in drugs and health products, as well as services for mail-order pharmacies. The operating segment Europe comprises the marketplace business of PromoFarma and Doctipharma. Majority of revenue is generated from Germany segment.
Sector
Healthcare
Industry
Pharmaceutical Retailers
Stock Style Box
Small Value
Total Number of Employees
1,453

Comparables

Valuation

Metric
ZRSEF
GALE
NBLY
Price/Earnings (Normalized)
21.3637.89
Price/Book Value
2.072.381.42
Price/Sales
0.970.940.95
Price/Cash Flow
13.8413.98
Price/Earnings
ZRSEF
GALE
NBLY

Financial Strength

Metric
ZRSEF
GALE
NBLY
Quick Ratio
1.270.880.40
Current Ratio
1.631.341.14
Interest Coverage
−5.3621.40−0.27
Quick Ratio
ZRSEF
GALE
NBLY

Profitability

Metric
ZRSEF
GALE
NBLY
Return on Assets (Normalized)
−12.29%10.03%−1.59%
Return on Equity (Normalized)
−28.68%20.87%−2.93%
Return on Invested Capital (Normalized)
−12.54%18.15%0.86%
Return on Assets
ZRSEF
GALE
NBLY
See how this stock stacks up to its competitors with Morningstar Investor

Pharmaceutical Retailers Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
WBA
Walgreens Boots Alliance IncXgmfyqgJqxz$15.0 Bil
RADLY
Raia Drogasil SA ADRQcrmg$8.4 Bil
ALBBY
Alibaba Health Information Technology Ltd ADRGnkylk$6.1 Bil
ALBHF
Alibaba Health Information Technology LtdLsfvkrj$6.1 Bil
CLCGY
Clicks Group Ltd ADRNgxhdtv$3.7 Bil
SDGCF
Sundrug Co LtdYrxdp$3.3 Bil
SGIPF
Sugi Holdings Co LtdClcs$2.6 Bil
SAEYY
Redcare Pharmacy NV ADRPyh$2.5 Bil
SHPPF
Redcare Pharmacy NVClrx$2.5 Bil

Sponsor Center